Univepotas Extended Release Tablet (Bepotastine Besilate)

Adult dose

Adults: Take 1 tablet once daily after a meal.

This medication should not be used in patients with hypersensitivity to the ingredients. Also, this medication contains lactose, so it should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with renal or liver impairment, as well as the elderly, should use this medication with extra caution. During the use of this medication, side effects such as drowsiness, headache, dizziness, dry mouth, nausea, vomiting, abdominal pain, and diarrhea may occur, so caution is advised. Additionally, blood counts or liver function tests may change, so regular testing may be necessary. This medication may cause drowsiness; therefore, it is advisable to avoid driving a car or operating dangerous machinery while taking it. Patients who have been on long-term steroid treatment should gradually reduce their steroid dosage when taking this medication and require medical supervision. Patients with reduced kidney function may have increased blood concentrations of this medication; therefore, starting at a low dose and adjusting or pausing doses if adverse reactions occur is necessary. For patients with seasonal allergic rhinitis, it is recommended to start taking this medication before symptoms begin and continue during the symptom period. If no effects manifest, it is advisable not to take this medication for an extended period. This medication may have intensified side effects when taken with alcohol, so it should not be taken together. Women who are pregnant or may become pregnant are advised not to use this medication, and if it is deemed necessary, consultation with a doctor is essential. Nursing mothers are also recommended to avoid breastfeeding while taking this medication. Safety in children has not been established; thus, administration to children should be approached with caution. Elderly patients may have an increased risk of elevated drug concentrations due to diminished kidney function, thus requiring careful monitoring. This medication may affect allergy testing; hence, it is recommended to stop taking it before the tests. Finally, this medication should be kept out of reach of children, and it is advantageous for safety and quality to avoid transferring it to another container.

• Drowsiness
• lethargy
• headache
• heaviness in the head
• dizziness
• dry mouth
• dry oral mucosa
• glossitis
• nausea
• vomiting

This medication should be stored in a tightly sealed container to protect it from air or moisture. It is best stored at room temperature between 1 and 30 degrees Celsius.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle